Isorad Ltd. was established 40 years ago, in order to commercialize technologies which have been developed in the SOREQ Nuclear Research Center (Soreq NRC) near Yavne, Israel.
Over the years, Isorad has been involved in the following areas:
Electro optical elements
Fuel Chemical Tagging
and many more
Currently, our main turnover (80%+) comes from the field of Nuclear Medicine, for which we develop and manufacture a broad range of products, aimed at both Diagnostic and Therapeutic purposes.
Isorad is capable of supplying any type of the SPECT range of Diagnostic products, PET Diagnostic products, MRI Contrast agents, and several Nuclear Therapeutic materials such as LU-177. In addition, our sterile aseptic manufacturing facility, built to meet the most advanced cGMP standards with two B/A Class Sterile Rooms, produces various labeling agents and other products, by Liquid Fill and Lyophilization processes. This facility is capable of providing the required infrastructure for pharmaceutical companies seeking to outsource part of their production activities.
With regard to R & D programs, Isorad seeks opportunities for cooperation in development with relevant commercial and academic entities.
On the realm of International Business Development activities, Isorad exports several products worldwide. We intend to broaden our international network, and we would welcome cooperation opportunities with relevant overseas companies and distributors. We hope you will find this website useful, and we welcome your feedback.